Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes

Molecular Pharmacology

Volumn 82, Issue 3, 2012, Pages 541-549

  Cha Molstad, Hyunjoo ^a   Xu, Guanlan ^a   Chen, Junqin ^a   Jing, Gu ^a   Young, Martin E ^b   Chatham, John C ^c   Shalev, Anath ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM CHANNEL BLOCKING AGENT; CCAAT BINDING FACTOR; HISTONE H4; MEMBRANE PROTEIN; NUCLEAR FACTOR Y; PROAPOPTOTIC THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEACETYLATION; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DNA BINDING; DOWN REGULATION; GENE DELETION; HEART MUSCLE CELL; IN VIVO STUDY; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACETYLATION; ANIMALS; APOPTOSIS; BINDING SITES; CALCINEURIN; CALCIUM CHANNEL BLOCKERS; CARRIER PROTEINS; CCAAT-BINDING FACTOR; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DIABETES MELLITUS, EXPERIMENTAL; HEART; HISTONES; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; SIGNAL TRANSDUCTION; THIOREDOXINS; TRANSCRIPTION, GENETIC; VERAPAMIL;

EID: 84865204096     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.078253     Document Type: Article

References (51)

1. Afzal N, Ganguly PK, Dhalla KS, Pierce GN, Singal PK, and Dhalla NS (1988) Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37:936-942.
2. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, et al. (2002) Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629-639.
3. Boudina S and Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213-3323.
4. Bozek K, Relógio A, Kielbasa SM, Heine M, Dame C, Kramer A, and Herzel H (2009) Regulation of clock-controlled genes in mammals. PLoS One 4:e4882.
5. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, and Richon VM (2002) The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 99:11700-11705.
6. Caretti G, Motta MC, and Mantovani R (1999) NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Mol Cell Biol 19:8591-8603.
7. Ceribelli M, Dolfini D, Merico D, Gatta R, Viganò AM, Pavesi G, and Mantovani R (2008) The histone-like NF-Y is a bifunctional transcription factor. Mol Cell Biol 28:2047-2058.
8. Cha-Molstad H, Saxena G, Chen J, and Shalev A (2009) Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. J Biol Chem 284:16898-16905.
9. Chen J, Cha-Molstad H, Szabo A, and Shalev A (2009) Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein. Am J Physiol Endocrinol Metab 296:E1133-E1139.
10. Chen J, Hui ST, Couto FM, Mungrue IN, Davis DB, Attie AD, Lusis AJ, Davis RA, and Shalev A (2008) Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta cell mass and protects against diabetes. FASEB J 22:3581-3594.
11. Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, and Campbell KP (2001) Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest 107:R1-R7.
12. Coustry F, Hu Q, de Crombrugghe B, and Maity SN (2001) CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure. J Biol Chem 276:40621-40630.
13. Czirják G and Enyedi P (2006) Targeting of calcineurin to an NFAT-like docking site is required for the calcium-dependent activation of the background K+ channel, TRESK. J Biol Chem 281:14677-14682.
14. Donati G, Gatta R, Dolfini D, Fossati A, Ceribelli M, and Mantovani R (2008) An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters. PLoS One 3:e2066.
15. Francia P, Cosentino F, Schiavoni M, Huang Y, Perna E, Camici GG, Lüscher TF, and Volpe M (2009) p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. J Mol Med 87:885-891.
16. Ghosh S, Ting S, Lau H, Pulinilkunnil T, An D, Qi D, Abrahani MA, and Rodrigues B (2004) Increased efflux of glutathione conjugate in acutely diabetic cardiomyocytes. Can J Physiol Pharmacol 82:879-887.
17. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
18. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG, et al. (2000) Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 164:6287-6295.
19. Le Flem L, Picard V, Emmerich J, Gandrille S, Fiessinger JN, Aiach M, and Alhenc-Gelas M (1999) Mutations in promoter region of thrombomodulin and venous thromboembolic disease. Arterioscler Thromb Vasc Biol 19:1098-1104.
20. Lindahl GE, Chambers RC, Papakrivopoulou J, Dawson SJ, Jacobsen MC, Bishop JE, and Laurent GJ (2002) Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J Biol Chem 277:6153-6161.
21. Liu Q, Yan H, Dawes NJ, Lu Y, and Zhu H (1998) Transcriptional activation of the p34cdc2 gene by cdc2 promoter binding factor/nuclear factor-Y in fetal rat ventricular myocytes. Circ Res 82:251-260.
22. Mellström B, Savignac M, Gomez-Villafuertes R, and Naranjo JR (2008) Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev 88:421-449.
23. Minn AH, Hafele C, and Shalev A (2005) Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 146:2397-2405.
24. Molkentin JD (2004) Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467-475.
25. Nishiyama A, Masutani H, Nakamura H, Nishinaka Y, and Yodoi J (2001) Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 52:29-33.
26. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J (1999) Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645-21650.
27. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, and Lee RT (2006) The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 281:21884-21891.
28. Peng Y and Jahroudi N (2002) The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. Blood 99:2408-2417.
29. Peng Y and Jahroudi N (2003) The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J Biol Chem 278:8385-8394.
30. Peng Y, Stewart D, Li W, Hawkins M, Kulak S, Ballermann B, and Jahroudi N (2007) Irradiation modulates association of NF-Y with histone-modifying cofactors PCAF and HDAC. Oncogene 26:7576-7583.
31. Reed BD, Charos AE, Szekely AM, Weissman SM, and Snyder M (2008) Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 4:e1000133.
32. Rodríguez A, Roy J, Martínez-Martínez S, López-Maderuelo MD, Niño-Moreno P, Ortí L, Pantoja-Uceda D, Pineda-Lucena A, Cyert MS, and Redondo JM (2009) A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. Mol Cell 33:616-626.
33. Rota M, LeCapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas ME, Esposito G, Vitale S, Urbanek K, Casarsa C, et al. (2006) Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99:42-52.
34. Roy B and Lee AS (1995) Transduction of calcium stress through interaction of the human transcription factor CBF with the proximal CCAAT regulatory element of the grp78/BiP promoter. Mol Cell Biol 15:2263-2274.
35. Saxena G, Chen J, and Shalev A (2010) Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.J Biol Chem 285:3997-4005.
36. Scarabelli TM, Knight RA, Rayment NB, Cooper TJ, Stephanou A, Brar BK, Lawrence KM, Santilli G, Latchman DS, Baxter GF, et al. (1999) Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunel technique enhanced with counterstains. J Immunol Methods 228:23-28.
37. Schulze PC, Liu H, Choe E, Yoshioka J, Shalev A, Bloch KD, and Lee RT (2006) Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity. Arterioscler Thromb Vasc Biol 26:2666-2672.
38. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, and Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369-30374.
39. Stavinoha MA, RaySpellicy JW, Essop MF, Graveleau C, Abel ED, Hart-Sailors ML, Mersmann HJ, Bray MS, and Young ME (2004) Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab 287:E888-E895.
40. Takahashi K, Hayashi N, Kaminogawa S, and Ra C (2006) Molecular mechanisms for transcriptional regulation of human high-affinity IgE receptor beta-chain gene induced by GM-CSF. J Immunol 177:4605-4611.
41. Wang Y, De Keulenaer GW, and Lee RT (2002) Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 277:26496-26500.
42. Xiang G, Seki T, Schuster MD, Witkowski P, Boyle AJ, See F, Martens TP, Kocher A, Sondermeijer H, Krum H, et al. (2005) Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem 280:39394-39402.
43. Xu G, Chen J, Jing G, and Shalev A (2012) Preventing â-cell loss and diabetes with calcium channel blockers. Diabetes 61:848-856.
44. Yamanaka H, Maehira F, Oshiro M, Asato T, Yanagawa Y, Takei H, and Nakashima Y (2000) A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem Biophys Res Commun 271:796-800.
45. Yamawaki H, Pan S, Lee RT, and Berk BC (2005) Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115:733-738.
46. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, et al. (2005) Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111:2073-2085.
47. Yoshioka J, Chutkow WA, Lee S, Kim JB, Yan J, Tian R, Lindsey ML, Feener EP, Seidman CE, Seidman JG, et al. (2012) Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest 122:267-279.
48. Yoshioka J, Schulze PC, Cupesi M, Sylvan JD, MacGillivray C, Gannon J, Huang H, and Lee RT (2004) Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 109:2581-2586.
49. Yu FX and Luo Y (2009) Tandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing molecules. PLoS One 4:e8397.
50. Yun J, Chae HD, Choi TS, Kim EH, Bang YJ, Chung J, Choi KS, Mantovani R, and Shin DY (2003) Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J Biol Chem 278:36966-36972.
51. Zhang Y, Chen B, Li Y, Chen J, Lou G, Chen M, and Zhou D (2008) Transcriptional regulation of the human PNRC promoter by NFY in HepG2 cells. J Biochem 143:675-683.